<page><title>Partington syndrome</title><url>https://medlineplus.gov/genetics/condition/partington-syndrome</url><content>Partington syndrome
To use the sharing features on this page, please enable JavaScript.
Description
Partington syndrome is a neurological disorder that causes intellectual disability along with a condition called focal dystonia that particularly affects movement of the hands. Partington syndrome usually occurs in males; when it occurs in females, the signs and symptoms are often less severe.
The intellectual disability associated with Partington syndrome usually ranges from mild to moderate. Some affected individuals have characteristics of autism spectrum disorders that affect communication and social interaction. Recurrent seizures (epilepsy) may also occur in Partington syndrome.
Focal dystonia of the hands is a feature that distinguishes Partington syndrome from other intellectual disability syndromes. Dystonias are a group of movement problems characterized by involuntary, sustained muscle contractions; tremors; and other uncontrolled movements. The term "focal" refers to a type of dystonia that affects a single part of the body, in this case the hands. In Partington syndrome, focal dystonia of the hands, which is called the Partington sign, begins in early childhood and gradually gets worse. This condition typically causes difficulty with grasping movements or using a pen or pencil.
People with Partington syndrome may also have dystonia affecting other parts of the body; dystonia affecting the muscles in the face and those involved in speech may cause impaired speech (dysarthria). People with this disorder may also have an awkward way of walking (gait). Signs and symptoms can vary widely, even within the same family.
Frequency
The prevalence of Partington syndrome is unknown. At least 20 cases have been described in the medical literature.
Causes
Partington syndrome is caused by mutations in the
ARX
gene. This gene provides instructions for producing a protein that regulates the activity of other genes. Within the developing brain, the ARX protein is involved with movement (migration) and communication of nerve cells (
neurons
). In particular, this protein regulates genes that play a role in the migration of specialized neurons (interneurons) to their proper location. Interneurons relay signals between other neurons.
The normal ARX protein contains four regions where a protein building block (amino acid) called alanine is repeated multiple times. These stretches of alanines are known as polyalanine tracts. The most common mutation that causes Partington syndrome, a duplication of genetic material written as c.428_451dup, adds extra alanines to the second polyalanine tract in the ARX protein. This type of mutation is called a polyalanine repeat expansion. The expansion likely impairs ARX protein function and may disrupt normal interneuron migration in the developing brain, leading to the intellectual disability and dystonia characteristic of Partington syndrome.
Learn more about the gene associated with Partington syndrome
ARX
Inheritance
This condition is inherited in an
X-linked recessive pattern
. The gene associated with this condition is located on the X chromosome, which is one of the two
sex chromosomes
. In males (who have only one X chromosome), one altered copy of the gene in each cell is sufficient to cause the condition. In females (who have two X chromosomes), a mutation would have to occur in both copies of the gene to cause the disorder. Because it is unlikely that females will have two altered copies of this gene, males are affected by X-linked recessive disorders much more frequently than females. Females with one altered copy of the gene may have some signs and symptoms related to the condition. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons.
Rarely, the genetic change that causes Partington syndrome is not inherited but occurs at some point during embryonic development. As cells continue to grow and divide, some of these cells will have the genetic change, and others will not (a situation known as mosaicism). The mosaic nature of these genetic changes lead to relatively mild features of Partington syndrome.
Other Names for This Condition
MRX36
Partington X-linked mental retardation syndrome
Partington-Mulley syndrome
PRTS
X-linked intellectual deficit-dystonia-dysarthria
X-linked mental retardation with dystonic movements, ataxia, and seizures
Additional Information &amp; Resources
Genetic Testing Information
Genetic Testing Registry: Partington syndrome
Genetic and Rare Diseases Information Center
Partington syndrome
Patient Support and Advocacy Resources
National Organization for Rare Disorders (NORD)
Catalog of Genes and Diseases from OMIM
PARTINGTON SYNDROME; PRTS
Scientific Articles on PubMed
PubMed
References
Cossee M, Faivre L, Philippe C, Hichri H, de Saint-Martin A, Laugel V,
Bahi-Buisson N, Lemaitre JF, Leheup B, Delobel B, Demeer B, Poirier K, Biancalana
V, Pinoit JM, Julia S, Chelly J, Devys D, Mandel JL. ARX polyalanine expansions
are highly implicated in familial cases of mental retardation with infantile
epilepsy and/or hand dystonia. Am J Med Genet A. 2011 Jan;155A(1):98-105. doi:
10.1002/ajmg.a.33785.
Citation on PubMed
Frints SG, Froyen G, Marynen P, Willekens D, Legius E, Fryns JP. Re-evaluation
of MRX36 family after discovery of an ARX gene mutation reveals mild neurological
features of Partington syndrome. Am J Med Genet. 2002 Nov 1;112(4):427-8. doi:
10.1002/ajmg.10628. No abstract available.
Citation on PubMed
Gronskov K, Diness B, Stahlhut M, Zilmer M, Tumer Z, Bisgaard AM,
Brondum-Nielsen K. Mosaicism for c.431_454dup in ARX causes a mild Partington
syndrome phenotype. Eur J Med Genet. 2014 May-Jun;57(6):284-7. doi:
10.1016/j.ejmg.2014.03.009. Epub 2014 Apr 13.
Citation on PubMed
Partington MW, Turner G, Boyle J, Gecz J. Three new families with X-linked
mental retardation caused by the 428-451dup(24bp) mutation in ARX. Clin Genet.
2004 Jul;66(1):39-45. doi: 10.1111/j.0009-9163.2004.00268.x.
Citation on PubMed
Poirier K, Lacombe D, Gilbert-Dussardier B, Raynaud M, Desportes V, de Brouwer
AP, Moraine C, Fryns JP, Ropers HH, Beldjord C, Chelly J, Bienvenu T. Screening
of ARX in mental retardation families: Consequences for the strategy of molecular
diagnosis. Neurogenetics. 2006 Mar;7(1):39-46. doi: 10.1007/s10048-005-0014-0.
Epub 2005 Oct 19.
Citation on PubMed
Sherr EH. The ARX story (epilepsy, mental retardation, autism, and cerebral
malformations): one gene leads to many phenotypes. Curr Opin Pediatr. 2003
Dec;15(6):567-71. doi: 10.1097/00008480-200312000-00004.
Citation on PubMed
Shoubridge C, Fullston T, Gecz J. ARX spectrum disorders: making inroads into
the molecular pathology. Hum Mutat. 2010 Aug;31(8):889-900. doi:
10.1002/humu.21288.
Citation on PubMed
Suri M. The phenotypic spectrum of ARX mutations. Dev Med Child Neurol. 2005
Feb;47(2):133-7. doi: 10.1017/s001216220500023x.
Citation on PubMed
Turner G, Partington M, Kerr B, Mangelsdorf M, Gecz J. Variable expression of
mental retardation, autism, seizures, and dystonic hand movements in two families
with an identical ARX gene mutation. Am J Med Genet. 2002 Nov 1;112(4):405-11.
doi: 10.1002/ajmg.10714.
Citation on PubMed
The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.
Official websites use .gov
A
.gov
website belongs to an official government
              organization in the United States.
Secure .gov websites use HTTPS
A
lock
(
Lock
Locked padlock icon
) or
https://
means youâ€™ve safely connected to
              the .gov website. Share sensitive information only on official,
              secure websites.</content></page>